Active and Passive Immunizations withBordetellaColonization Factor A Protect Mice against Respiratory Challenge withBordetella bronchiseptica
- 1 February 2009
- journal article
- Published by American Society for Microbiology in Infection and Immunity
- Vol. 77 (2) , 885-895
- https://doi.org/10.1128/iai.01076-08
Abstract
Bordetella colonizationfactorA(BcfA) is an outer membrane immunogenic protein, which is critical for efficient colonization of the murine respiratory tract. These properties of BcfA prompted us to examine its utility in inducing a protective immune response againstBordetella bronchisepticain a mouse model of intranasal infection. Mice vaccinated with BcfA demonstrated reduced pathology in the lungs and harbored lower bacterial burdens in the respiratory tract. Immunization with BcfA led to the generation of BcfA-specific antibodies in both the sera and lungs, and passive immunization led to the reduction ofB. bronchisepticain the tracheas and lungs. These results suggest that protection after immunization with BcfA is mediated in part by antibodies against BcfA. To further investigate the mechanism of BcfA-induced immune clearance, we examined the role of neutrophils and macrophages. Our results demonstrate that neutrophils are critical for anti-BcfA antibody-mediated clearance and that opsonization with anti-BcfA serum enhances phagocytosis ofB. bronchisepticaby murine macrophages. We show that immunization with BcfA results in the production of gamma interferon and subclasses of immunoglobulin G antibodies that are consistent with the induction of a Th1-type immune response. In combination, our findings suggest that the mechanism of BcfA-mediated immunity involves humoral and cellular responses. Expression of BcfA is conserved among multiple clinical isolates ofB. bronchiseptica. Our results demonstrate the striking protective efficacy of BcfA-mediated immunization, thereby highlighting its utility as a potential vaccine candidate. These results also provide a model for the development of cell-free vaccines againstB. bronchiseptica.Keywords
This publication has 49 references indexed in Scilit:
- Replacement of Adenylate Cyclase Toxin in a Lineage of Bordetella bronchisepticaJournal of Bacteriology, 2008
- Persistent Bordetella bronchiseptica Pneumonia in an Immunocompetent Infant and Genetic Comparison of Clinical Isolates with Kennel Cough Vaccine StrainsClinical Infectious Diseases, 2008
- Bordetella pertussis Expresses a Functional Type III Secretion System That Subverts Protective Innate and Adaptive Immune ResponsesInfection and Immunity, 2008
- Oral Vaccination withSalmonella entericaas a Cruzipain-DNA Delivery System Confers Protective Immunity againstTrypanosoma cruziInfection and Immunity, 2008
- The Bordetella Bps Polysaccharide Is Critical for Biofilm Development in the Mouse Respiratory TractJournal of Bacteriology, 2007
- Use of a Genetically Defined Double Mutant Strain of Bordetella bronchiseptica Lacking Adenylate Cyclase and Type III Secretion as a Live VaccineInfection and Immunity, 2007
- Differential Bvg Phase-Dependent Regulation and Combinatorial Role in Pathogenesis of Two Bordetella Paralogs, BipA and BcfAJournal of Bacteriology, 2007
- Comparison of the Genome Sequence of the Poultry PathogenBordetella aviumwith Those ofB. bronchiseptica,B. pertussis, andB. parapertussisReveals Extensive Diversity in Surface Structures Associated with Host InteractionJournal of Bacteriology, 2006
- Hospital-Acquired Bordetella bronchiseptica Infection following Hematopoietic Stem Cell TransplantationJournal of Clinical Microbiology, 2006
- Molecular Pathogenesis, Epidemiology, and Clinical Manifestations of Respiratory Infections Due toBordetella pertussisand OtherBordetellaSubspeciesClinical Microbiology Reviews, 2005